Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management
- PMID: 16198993
- DOI: 10.1016/j.optm.2005.07.003
Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management
Abstract
Background: Optic neuritis (ON), defined as an inflammatory demyelinating optic neuropathy, is a frequent cause of visual loss owing to optic nerve dysfunction in young or middle-aged patients. ON can be seen in isolation or in association with multiple sclerosis (MS). Highlighting the importance of this association is the fact that approximately 20% of patients with MS will present with ON.
Methods: Review was conducted of the literature and pertinent clinical trials.
Conclusion: Although the vision prognosis of patients with ON is excellent, with or without the use of corticosteroids, a minority of patients will suffer from significantly poor vision. ON may be the heralding manifestation of MS; the risk stratification for the future development of MS in patients presenting with ON can be determined by the number of white matter lesions on the baseline cerebral magnetic resonance imaging study. To date, 2 randomized, placebo-controlled studies have found that patients with a clinically isolated demyelinating syndrome, such as ON, at risk for MS, may benefit from the early institution of a disease-modifying drug.
Similar articles
-
Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations.Neurologist. 2008 Jul;14(4):207-23. doi: 10.1097/NRL.0b013e31816f27fe. Neurologist. 2008. PMID: 18617847 Review.
-
[Optic neuritis--diagnosis, treatment and follow up].Tidsskr Nor Laegeforen. 2005 Feb 17;125(4):425-8. Tidsskr Nor Laegeforen. 2005. Retraction in: Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2056. PMID: 15742012 Retracted. Norwegian.
-
Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.Ophthalmology. 2006 Feb;113(2):323.e1-323.e2. doi: 10.1016/j.ophtha.2005.10.017. Epub 2006 Jan 10. Ophthalmology. 2006. PMID: 16406544
-
Evolving management of optic neuritis and multiple sclerosis.Am J Ophthalmol. 2005 Jun;139(6):1101-8. doi: 10.1016/j.ajo.2005.01.031. Am J Ophthalmol. 2005. PMID: 15953446 Review.
-
Multiple sclerosis, the great masquerader: an atypical ocular presentation.J Am Optom Assoc. 1997 Dec;68(12):757-62. J Am Optom Assoc. 1997. PMID: 9635381
Cited by
-
Corticosteroids for treating optic neuritis.Cochrane Database Syst Rev. 2012 Apr 18;4(4):CD001430. doi: 10.1002/14651858.CD001430.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2015 Aug 14;(8):CD001430. doi: 10.1002/14651858.CD001430.pub4. PMID: 22513900 Free PMC article. Updated.
-
Corticosteroids for treating optic neuritis.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001430. doi: 10.1002/14651858.CD001430.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD001430. doi: 10.1002/14651858.CD001430.pub3. PMID: 17253459 Free PMC article. Updated.
-
Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment.Ther Clin Risk Manag. 2008 Jun;4(3):627-30. doi: 10.2147/tcrm.s2515. Ther Clin Risk Manag. 2008. PMID: 18827858 Free PMC article.
-
Corticosteroids for treating optic neuritis.Cochrane Database Syst Rev. 2015 Aug 14;2015(8):CD001430. doi: 10.1002/14651858.CD001430.pub4. Cochrane Database Syst Rev. 2015. PMID: 26273799 Free PMC article.
-
Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.Clin Rheumatol. 2013 Jun;32(6):743-53. doi: 10.1007/s10067-013-2252-0. Epub 2013 Apr 16. Clin Rheumatol. 2013. PMID: 23588881 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous